FDG-PET-CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality TreatmentReportar como inadecuado




FDG-PET-CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Nuclear Medicine and Molecular Imaging

, Volume 49, Issue 3, pp 237–240

First Online: 13 February 2015Received: 28 August 2014Revised: 16 January 2015Accepted: 19 January 2015DOI: 10.1007-s13139-015-0321-9

Cite this article as: Quak, E., Kovacs, I., Oyen, W.J.G. et al. Nucl Med Mol Imaging 2015 49: 237. doi:10.1007-s13139-015-0321-9

Abstract

The value of F-18-fluorodeoxyglucose positron emission tomography-computed tomography FDG-PET-CT in detecting viable tumours in patients with metastasised non-seminomatous testicular cancer and residual and new masses post chemotherapy remains to be determined. We describe the case of a 41-year-old patient with metastasised non-seminomatous testicular cancer, with both retroperitoneal and extra-retroperitoneal residual masses post chemotherapy, for whom FDG-PET-CT guided major treatment decisions. FDG-PET-CT correctly identified the locations of viable tumour, as was proved by histology, and successfully guided surgery. In conclusion, in selected cases surveillance of patients with non-seminomatous testicular cancer with FDG-PET-CT can guide major treatment decisions when considering surgery for metastatic disease.

KeywordsFDG-PET-CT Testicular cancer Teratoma Germ cell tumour  Download fulltext PDF



Autor: Elske Quak - Iringo Kovacs - Wim J. G. Oyen - Winette T. A. van der Graaf

Fuente: https://link.springer.com/



DESCARGAR PDF




Documentos relacionados